Sheel Biotech Ratios

Sheel Biotech Ltd Ratios

The Sheel Biotech Ltd Ratios page provides a complete fundamental analysis of Sheel Biotech Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Sheel Biotech Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Sheel Biotech Ltd (NSE: SHEEL, BSE: 92363) is currently trading at ₹42.40, with a market capitalization of ₹862.95M. As a major player in the Process industries sector and Agricultural commodities/Milling industry, Sheel Biotech Ltd remains a key stock for fundamental analysis using Sheel Biotech Ltd Ratios.

Sheel Biotech Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Sheel Biotech Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Sheel Biotech Ltd Ratios.

Historically, the Sheel Biotech Ltd P/E ratio has shown strong fluctuations:

The decline in Sheel Biotech Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Sheel Biotech Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.

Historical P/B trend:

Sheel Biotech Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Sheel Biotech Ltd P/S ratio currently stands at 0, an important part of Sheel Biotech Ltd Ratios for revenue valuation.

Historical P/S ratio:

A stable or declining Sheel Biotech Ltd P/S ratio indicates cautious market sentiment.

Sheel Biotech Ltd Price to Cash Flow Ratio (P/CF)

The Sheel Biotech Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Sheel Biotech Ltd Price to Cash Flow Ratio:

The declining Sheel Biotech Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Sheel Biotech Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Sheel Biotech Ltd EV currently stands at ₹0, representing the total company valuation including debt.

Historical EV trend:

Sheel Biotech Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Sheel Biotech Ltd EV/EBITDA ratio is currently 0, a key metric in Sheel Biotech Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

Stable Sheel Biotech Ltd EV/EBITDA indicates balanced valuation.

Sheel Biotech Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Sheel Biotech Ltd D/E ratio is currently 0, reflecting leverage and financial stability.

Historical D/E:

Sheel Biotech Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Sheel Biotech Ltd ROE currently stands at 0%, showing profitability and capital efficiency.

Historical ROE:

Declining ROE indicates pressure on profitability.

Sheel Biotech Ltd Ratios Analysis Summary

The Sheel Biotech Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Sheel Biotech Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Sheel Biotech Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.